Piata farmaceutica din Romania a crescut cu 13,4% in 2018, la 3,4 miliarde euro
Source: Financiarul.ro.
Growth of the Pharmaceutical Market in Romania
In 2018, Romania’s pharmaceutical sector, encompassing both prescription and over-the-counter medications, experienced a remarkable growth of 13.4% compared to the previous year, reaching a total market value of €3.374 billion.
Price Trends and Manufacturer Insights
In the same year, Zentiva reported an average producer price of 7.84 lei, marking a 4% increase from the 7.52 lei average in 2017. For context, the overall average producer price across the local pharmaceutical market was 25.9 lei in 2018, reflecting an 8% rise from the previous year’s average of 24 lei, as indicated in a report submitted by Zentiva to the Bucharest Stock Exchange (BVB).
Key Players in the Market
Notable local pharmaceutical manufacturers include Ranbaxy (Terapia) from Cluj, Antibiotice from Iasi, Labormed, and Biofarm. Major importers of pharmaceutical products consist of global giants such as Sanofi, Hoffmann-La Roche, Novartis, Pfizer, and GlaxoSmithKline.
Product Pricing and Portfolio
The average price of Zentiva’s products (both finished goods and raw materials) per pharmaceutical unit sold was 4.37 lei in 2018, down from 4.61 lei in 2017. This decline can be attributed to the product mix and packaging variations. Zentiva’s portfolio includes 130 human-use products, available in solid forms (tablets, capsules, pellets) and injectable solutions.
Export Performance and Revenue Breakdown
Last year, exports of finished products and raw materials accounted for 59% of total sales revenue, amounting to 252 million lei, compared to 53% in 2017, which was 213 million lei. These exports were facilitated through a subsidiary of the Sanofi Group (Sanofi Winthrop) and a company within the Zentiva Group (Zentiva k.s.), primarily targeting markets within the European Union. The share of over-the-counter (OTC) products in Zentiva’s sales was 11% in 2018, down from 14% the previous year.
Zentiva’s Role in the European Market
Zentiva stands as a prominent European pharmaceutical manufacturer, catering to patients across Europe, the Middle East, and Africa. The company employs over 2,500 individuals and operates a network of production facilities, including plants in Prague and Bucharest.
Local Operations and Workforce
In Romania, Zentiva employs approximately 750 staff members and operates a manufacturing unit that produces medications for both the domestic market and other European countries.
Source: wall-street.ro
